MAPK3 and thyroid cancer: IL−17B dose dependently promoted the invasion, growth and migration of thyroid cancer cells. IL-17RB induced ERK1/2 activation pathway and increased MMP-9 expression Thyroid cancer cells express IL-17RA, IL-17RB and IL-17RC